Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Grutters

Showing results (21-30 of 259) with videos related to

Pageof 26
Sort By:
Current Opinion in Pulmonary Medicine|June 30, 2017
Cardiac sarcoidosis: challenges in clinical practiceAnne L Bakker, Jan C Grutters, Ruth G Keijsers, et al.
Current Opinion in Pulmonary Medicine|July 22, 2014
Cytotoxic agents in sarcoidosis: which one should we choose?Adriane D M Vorselaars, Johanna P Cremers, Jan C Grutters, et al.
Clinical Nuclear Medicine|August 22, 2007
PET scintigraphy of etoposide-induced pulmonary toxicityMartijn C Post, Jan C Grutters, J Fred Verzijlbergen, et al.
Respiratory Research|June 30, 2010
Clinical use of biomarkers of survival in pulmonary fibrosisMichiel Thomeer, Jan C Grutters, Wim A Wuyts, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|February 18, 2021
Genetic disorders of the surfactant system: focus on adult diseaseColine H M van Moorsel, Joanne J van der Vis, Jan C Grutters
Current Opinion in Pulmonary Medicine|August 1, 2019
Patient perspectives in sarcoidosisSanne J van Helmondt, Louis B Polish, Marc A Judson, et al.
BMC Pulmonary Medicine|January 31, 2026
Understanding emotional and practical challenges of initiating oxygen therapy in pulmonary fibrosis: insights from a patient-centered surveyMarjolein Drent, Lian Trapman, Miranda Hennevelt-Leenen, et al.
The European Respiratory Journal|September 29, 2012
Imaging the inflammatory activity of sarcoidosisRuth G M Keijsers, Daniel A F van den Heuvel, Jan C Grutters
American Journal of Respiratory and Critical Care Medicine|March 25, 2006
Interleukin-18-607 promoter polymorphism in sarcoidosis: ignoring "negative" resultsRob Janssen, Adrian Kruit, Jan C Grutters, et al.
American Journal of Respiratory and Critical Care Medicine|June 4, 2013
Primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis: one step at a timePaolo Spagnolo, Fabrizio Luppi, Toby M Maher, et al.
Pageof 26

Showing results (21-30 of 259) with videos related to

Sort By:
Pageof 26
Current Opinion in Pulmonary Medicine|June 30, 2017
Cardiac sarcoidosis: challenges in clinical practiceAnne L Bakker, Jan C Grutters, Ruth G Keijsers, et al.
Current Opinion in Pulmonary Medicine|July 22, 2014
Cytotoxic agents in sarcoidosis: which one should we choose?Adriane D M Vorselaars, Johanna P Cremers, Jan C Grutters, et al.
Clinical Nuclear Medicine|August 22, 2007
PET scintigraphy of etoposide-induced pulmonary toxicityMartijn C Post, Jan C Grutters, J Fred Verzijlbergen, et al.
Respiratory Research|June 30, 2010
Clinical use of biomarkers of survival in pulmonary fibrosisMichiel Thomeer, Jan C Grutters, Wim A Wuyts, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|February 18, 2021
Genetic disorders of the surfactant system: focus on adult diseaseColine H M van Moorsel, Joanne J van der Vis, Jan C Grutters
Current Opinion in Pulmonary Medicine|August 1, 2019
Patient perspectives in sarcoidosisSanne J van Helmondt, Louis B Polish, Marc A Judson, et al.
BMC Pulmonary Medicine|January 31, 2026
Understanding emotional and practical challenges of initiating oxygen therapy in pulmonary fibrosis: insights from a patient-centered surveyMarjolein Drent, Lian Trapman, Miranda Hennevelt-Leenen, et al.
The European Respiratory Journal|September 29, 2012
Imaging the inflammatory activity of sarcoidosisRuth G M Keijsers, Daniel A F van den Heuvel, Jan C Grutters
American Journal of Respiratory and Critical Care Medicine|March 25, 2006
Interleukin-18-607 promoter polymorphism in sarcoidosis: ignoring "negative" resultsRob Janssen, Adrian Kruit, Jan C Grutters, et al.
American Journal of Respiratory and Critical Care Medicine|June 4, 2013
Primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis: one step at a timePaolo Spagnolo, Fabrizio Luppi, Toby M Maher, et al.
Pageof 26